4.7 Article

Identification of novel SARS-CoV-2 RNA dependent RNA polymerase (RdRp) inhibitors: From in silico screening to experimentally validated inhibitory activity

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

R. L. Gottlieb et al.

Summary: In symptomatic, nonhospitalized high-risk Covid-19 patients, a 3-day course of remdesivir significantly reduced the risk of hospitalization or death compared to placebo, with acceptable safety profile.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Infectious Diseases

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader et al.

Summary: A study conducted in COVID-19 patients admitted to hospital and requiring oxygen support found that remdesivir did not show significant clinical benefits compared to standard care alone.

LANCET INFECTIOUS DISEASES (2022)

Article Immunology

Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care

Susan A. Olender et al.

Summary: In a comparative analysis, remdesivir was found to be associated with significantly higher recovery rates and a 62% reduced mortality rate compared to standard-of-care treatment by day 14 in patients with severe COVID-19.

CLINICAL INFECTIOUS DISEASES (2021)

Letter Infectious Diseases

Estimating clinical SARS-CoV-2 infectiousness in Vero E6 and primary airway epithelial cells

Manel Essaidi-Laziosi et al.

LANCET MICROBE (2021)

Article Biochemistry & Molecular Biology

Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease

Yuxi Lin et al.

Summary: Xanthohumol, a small molecule from hops, has shown potent inhibitory effects against various coronaviruses by targeting M-pro, making it a promising antiviral drug candidate.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Structure-based peptide design targeting intrinsically disordered proteins: Novel histone H4 and H2A peptidic inhibitors

Kanin Wichapong et al.

Summary: Research has shown that targeting intrinsically disordered proteins and protein regions is a feasible and emerging strategy in drug discovery. By utilizing structure-based methods, peptidic inhibitors have been successfully developed to inhibit specific proteins, which can prevent cell death and reduce the progression of atherosclerosis.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Review Medicine, Research & Experimental

Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials

Ahmad Al-Abdouh et al.

Summary: Remdesivir in COVID-19 patients is associated with increased rates of recovery and hospital discharge, along with decreased rates of serious adverse events. However, it does not significantly reduce the time to clinical improvement or mortality.

CONTEMPORARY CLINICAL TRIALS (2021)

News Item Multidisciplinary Sciences

The coronavirus is here to stay - here's what that means

Nicky Phillips

Summary: Scientists expect the virus that causes COVID-19 to become endemic and pose less danger over time, according to a Nature survey.

NATURE (2021)

Article Virology

Significant Inhibition of Porcine Epidemic Diarrhea Virus In Vitro by Remdesivir, Its Parent Nucleoside and β-d-N4-hydroxycytidine

Yuanchao Xie et al.

Summary: In recent years, the increased virulence of the porcine epidemic diarrhea virus has caused significant economic losses to the pig industry worldwide. Researchers have discovered three broad-spectrum antiviral nucleoside analogs, with RDV-N showing the strongest antiviral activity against PEDV. This compound has the potential to be a promising broad-spectrum antiviral nucleoside, with the need to enhance its oral bioavailability through structural modifications.

VIROLOGICA SINICA (2021)

Review Microbiology

Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola

Victoria C. Yan et al.

Summary: Remdesivir, approved for COVID-19, has shown contentious clinical efficacy, puzzling many due to discrepancies between promising preclinical data and lackluster clinical performance. Critical evaluation of underlying assumptions can help anticipate underwhelming clinical outcomes given limitations in drug efficacy testing and species differences in drug metabolism.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Virology

Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset-Lessons Learned

Lars Dolken et al.

Summary: After more than one year of the COVID-19 pandemic, antiviral treatment options remain limited. Despite some clinical efficacy in individual cases, major trials have failed to confirm the effectiveness of antiviral drugs like remdesivir. Suggestions for improving future clinical trials and responses to pandemics are discussed.

VIRUSES-BASEL (2021)

Article Multidisciplinary Sciences

Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant

Sten Ilmjaerv et al.

Summary: The combination of G614 and L323 mutations in the Spike protein of SARS-CoV-2 creates a viral G/L variant that has replaced the initial D/P variant, with P323L mutation being crucial for the current variant's epidemiological success. While there is no significant correlation between COVID-19 mortality rates in different countries and the prevalence of Wuhan versus G/L variants, the G/L variant demonstrates major epidemiological supremacy over the original variant in terms of speed of emergence and ultimate predominance in individual countries.

SCIENTIFIC REPORTS (2021)

Article Cell Biology

Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice

David R. Martinez et al.

Summary: Research shows that a combination of two mAbs in clinical trials has strong antiviral effects and therapeutic efficacy against certain variants, while combining RDV and antibodies slightly improves treatment outcomes, supporting the continued use of RDV to treat SARS-CoV-2 infections.

CELL REPORTS (2021)

Article Biochemistry & Molecular Biology

Dissecting nucleotide selectivity in viral RNA polymerases

Chunhong Long et al.

Summary: This article reviews the structural biology and computational clues of representative single-subunit viral polymerases related to the SARS-CoV-2 RdRp. It compares the nucleotide selectivity among different viruses' RdRps and explores the structural and biochemical characteristics of SARS-CoV-2 RdRp. Additionally, the article discusses computational findings on phage T7 RNA polymerase and human mitochondria RNAP, highlighting the importance of proofreading strategies in synthesizing large viral genomes.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Review Pharmacology & Pharmacy

Remdesivir: A Closer Look at Its Effect in COVID-19 Pandemic

Huda R. Taha et al.

Summary: Remdesivir showed promising beneficial effects against new variants of SARS-CoV-2, but more clinical evidence is needed to confirm this effect.

PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

Remdesivir: From Ebola to COVID-19

M. Gabriella Santoro et al.

Summary: Human coronaviruses were initially thought to cause mild respiratory diseases, but challenges came with the SARS and MERS outbreaks. Remdesivir, originally developed for Ebola, has shown potential in treating SARS-CoV-2, with some trials showing positive results while others have been negative.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Structure of replicating SARS-CoV-2 polymerase

Hauke S. Hillen et al.

NATURE (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

RdRp mutations are associated with SARS-CoV-2 genome evolution

Doga Eskier et al.

PEERJ (2020)

Article Chemistry, Medicinal

Decoding SARS-CoV-2 Transmission and Evolution and Ramifications for COVID-19 Diagnosis, Vaccine, and Medicine

Rui Wang et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)

Review Public, Environmental & Occupational Health

SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus

Kuldeep Dhama et al.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)

Article Chemistry, Medicinal

ZINC20-A Free Ultralarge-Scale Chemical Database for Ligand Discovery

John J. Irwin et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)

Article Multidisciplinary Sciences

Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors

Robert N. Kirchdoerfer et al.

NATURE COMMUNICATIONS (2019)

Article Cell Biology

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Timothy P. Sheahan et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Review Biochemistry & Molecular Biology

Molecular Evolution of Human Coronavirus Genomes

Diego Forni et al.

TRENDS IN MICROBIOLOGY (2017)

Article Genetics & Heredity

Origin and Evolution of RNA-Dependent RNA Polymerase

Savio T. de Farias et al.

FRONTIERS IN GENETICS (2017)

Article Biotechnology & Applied Microbiology

Genetic manipulation of porcine epidemic diarrhoea virus recovered from a full-length infectious cDNA clone

Juggragarn Jengarn et al.

JOURNAL OF GENERAL VIROLOGY (2015)

Article Biochemical Research Methods

Unipro UGENE: a unified bioinformatics toolkit

Konstantin Okonechnikov et al.

BIOINFORMATICS (2012)

Article Biochemical Research Methods

BLAST plus : architecture and applications

Christiam Camacho et al.

BMC BIOINFORMATICS (2009)

Article Biochemical Research Methods

MUSCLE: a multiple sequence alignment method with reduced time and space complexity

RC Edgar

BMC BIOINFORMATICS (2004)

Article Biochemistry & Molecular Biology

Improved protein-ligand docking using GOLD

ML Verdonk et al.

PROTEINS-STRUCTURE FUNCTION AND GENETICS (2003)

Article Biochemical Research Methods

MatGAT: An application that generates similarity/identity matrices using protein or DNA sequences

JJ Campanella et al.

BMC BIOINFORMATICS (2003)